Dean W. Selleseth

535 total citations
16 papers, 435 citations indexed

About

Dean W. Selleseth is a scholar working on Epidemiology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Dean W. Selleseth has authored 16 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Organic Chemistry. Recurrent topics in Dean W. Selleseth's work include Cytomegalovirus and herpesvirus research (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Herpesvirus Infections and Treatments (4 papers). Dean W. Selleseth is often cited by papers focused on Cytomegalovirus and herpesvirus research (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Herpesvirus Infections and Treatments (4 papers). Dean W. Selleseth collaborates with scholars based in United States, Slovakia and China. Dean W. Selleseth's co-authors include F. Leslie Boyd, George A. Freeman, Kristjan S. Gudmundsson, Karen K. Biron, Katrina L. Creech, Brian A. Johns, Scott H. Allen, Mark Ellis, Richard J. Harvey and Connie J. Sexton and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry and Antiviral Research.

In The Last Decade

Dean W. Selleseth

16 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean W. Selleseth United States 11 188 165 111 79 76 16 435
Susan Cox Sweden 13 104 0.6× 137 0.8× 144 1.3× 115 1.5× 107 1.4× 27 465
В. Л. Андронова Russia 13 165 0.9× 140 0.8× 105 0.9× 142 1.8× 52 0.7× 68 427
Hubert Barucki United Kingdom 8 199 1.1× 245 1.5× 84 0.8× 108 1.4× 21 0.3× 11 482
Shaoman Zhou United States 14 199 1.1× 273 1.7× 146 1.3× 102 1.3× 24 0.3× 27 564
M. R. HARNDEN United Kingdom 10 197 1.0× 139 0.8× 124 1.1× 117 1.5× 37 0.5× 29 390
Ganesh D. Kini United States 15 135 0.7× 277 1.7× 149 1.3× 231 2.9× 79 1.0× 30 566
Gussie Arnett United States 12 174 0.9× 165 1.0× 192 1.7× 255 3.2× 59 0.8× 20 507
Galegov Ga Russia 11 169 0.9× 98 0.6× 89 0.8× 139 1.8× 33 0.4× 103 382
Aleš Merta Czechia 10 227 1.2× 81 0.5× 249 2.2× 225 2.8× 85 1.1× 15 479
Toru Kontani Japan 11 177 0.9× 101 0.6× 36 0.3× 67 0.8× 30 0.4× 15 362

Countries citing papers authored by Dean W. Selleseth

Since Specialization
Citations

This map shows the geographic impact of Dean W. Selleseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean W. Selleseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean W. Selleseth more than expected).

Fields of papers citing papers by Dean W. Selleseth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean W. Selleseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean W. Selleseth. The network helps show where Dean W. Selleseth may publish in the future.

Co-authorship network of co-authors of Dean W. Selleseth

This figure shows the co-authorship network connecting the top 25 collaborators of Dean W. Selleseth. A scholar is included among the top collaborators of Dean W. Selleseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean W. Selleseth. Dean W. Selleseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Selleseth, Dean W., et al.. (2018). In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus. Antiviral Research. 158. 255–263. 21 indexed citations
2.
Foster, Scott A., Dean W. Selleseth, Mark N. Prichard, et al.. (2014). Emerging Combination Activity and Resistance Profile for Brincidofovir (CMX001) in CMV Prevention and Treatment. The Journal of Heart and Lung Transplantation. 33(4). S152–S152. 1 indexed citations
3.
Harvey, Richard J., Kevin Brown, Qin Zhang, et al.. (2009). GSK983: A novel compound with broad-spectrum antiviral activity. Antiviral Research. 82(1). 1–11. 52 indexed citations
4.
Allen, Scott H., Brian A. Johns, Kristjan S. Gudmundsson, et al.. (2005). Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 14(4). 944–954. 38 indexed citations
5.
Gudmundsson, Kristjan S., Brian A. Johns, Zhicheng Wang, et al.. (2005). Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses. Bioorganic & Medicinal Chemistry. 13(18). 5346–5361. 48 indexed citations
6.
Ferris, Robert G., Richard Hazen, M H St Clair, et al.. (2005). Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor. Antimicrobial Agents and Chemotherapy. 49(10). 4046–4051. 51 indexed citations
7.
Johns, Brian A., Kristjan S. Gudmundsson, Elizabeth M. Turner, et al.. (2005). Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents. Bioorganic & Medicinal Chemistry. 13(7). 2397–2411. 50 indexed citations
8.
Underwood, Mark, Robert G. Ferris, Dean W. Selleseth, et al.. (2004). Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus. Antimicrobial Agents and Chemotherapy. 48(5). 1647–1651. 41 indexed citations
9.
Selleseth, Dean W., Christine L. Talarico, Teresa Miller, et al.. (2003). Interactions of 1263W94 with Other Antiviral Agents in Inhibition of Human Cytomegalovirus Replication. Antimicrobial Agents and Chemotherapy. 47(4). 1468–1471. 31 indexed citations
10.
Freeman, George A., Dean W. Selleseth, Janet L. Rideout, & Richard J. Harvey. (2000). Benzimidazole 2′-Isonucleosides: Design, Synthesis, and Antiviral Activity of 2-Substituted-5,6-Dichlorobenzimidazole 2′-Isonucleosides. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 155–174. 6 indexed citations
11.
Chan, Joseph H., Stanley D. Chamberlain, Karen K. Biron, et al.. (2000). Synthesis and Evaluation of a Series of 2′-Deoxy Analogues of The Antiviral Agent 5,6-Dichloro-2-Isopropylamino-1-(β-L-Ribofuranosyl)-1H-Benzimidazole (1263W94). Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 101–123. 7 indexed citations
12.
Johnson, Calvin M., et al.. (1995). Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus. Veterinary Immunology and Immunopathology. 46(1-2). 169–180. 7 indexed citations
13.
Condreay, Lynn D., Robert W. Jansen, Lance C. Johnson, et al.. (1994). Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrobial Agents and Chemotherapy. 38(3). 616–619. 33 indexed citations
14.
Hostetler, Karl Y., Douglas D. Richman, Ch. Sridhar, et al.. (1994). Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice. Antimicrobial Agents and Chemotherapy. 38(12). 2792–2797. 18 indexed citations
15.
Selleseth, Dean W., et al.. (1994). Feline lymphoid tissues engrafted into scid mice maintain morphologic structure and produce feline immunoglobulin.. PubMed. 44(4). 313–8. 4 indexed citations
16.
Ellis, Mark, Ryan Waters, Edgar L. Hill, et al.. (1989). Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrobial Agents and Chemotherapy. 33(3). 304–310. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Cox Breakdown of academic impact, for papers by В. Л. Андронова Breakdown of academic impact, for papers by Hubert Barucki Breakdown of academic impact, for papers by Shaoman Zhou Breakdown of academic impact, for papers by M. R. HARNDEN Breakdown of academic impact, for papers by Ganesh D. Kini Breakdown of academic impact, for papers by Gussie Arnett Breakdown of academic impact, for papers by Galegov Ga Breakdown of academic impact, for papers by Aleš Merta Breakdown of academic impact, for papers by Toru Kontani
Rankless by CCL
2026